Literature DB >> 8292491

Learning and sexual deficiencies in transgenic mice carrying a chimeric vasoactive intestinal peptide gene.

I Gozes1, J Glowa, D E Brenneman, S K McCune, E Lee, H Westphal.   

Abstract

The molecular mechanisms responsible for behavior are largely unknown. A state of the art model, paving the path from genes to behavior, is offered by transgenic animals. Candidate molecules are classic neuropeptides, such as vasoactive intestinal peptide (VIP). Transgenic mice harboring a chimeric VIP gene driven by the polyoma promoter were produced. Behavioral studies revealed learning impairment and prolonged retardation in memory acquisition in the genetically altered animals. Furthermore, reduced performance was observed when the male transgenic mice were tested for sexual activity in the presence of receptive females. Surprisingly, radioimmunoassays showed an approx 20% decrease in the VIP content of the transgenic mice brains. To directly assess genetically reduced VIP content as a cause for learning impairment, transgenic mice carrying diphtheria toxin-encoding sequences driven by the rat VIP promoter were created. These animals had reduced brain VIP and exhibited deficiencies in learning abilities, strongly supporting an important neurobiological function for VIP in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8292491     DOI: 10.1007/BF02782501

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  39 in total

1.  Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene.

Authors:  V L Tybulewicz; M L Tremblay; M E LaMarca; R Willemsen; B K Stubblefield; S Winfield; B Zablocka; E Sidransky; B M Martin; S P Huang
Journal:  Nature       Date:  1992-06-04       Impact factor: 49.962

2.  Vasoactive intestinal peptide potentiates sexual behavior: inhibition by novel antagonist.

Authors:  I Gozes; E Meltzer; S Rubinrout; D E Brenneman; M Fridkin
Journal:  Endocrinology       Date:  1989-12       Impact factor: 4.736

3.  Functional analysis of the regulatory region of polyoma mutant F9-1 DNA.

Authors:  E Böhnlein; K Chowdhury; P Gruss
Journal:  Nucleic Acids Res       Date:  1985-07-11       Impact factor: 16.971

Review 4.  Regulation of the vasoactive intestinal peptide receptor.

Authors:  G Rosselin; A Anteunis; A Astesano; C Boissard; P Gali; G Hejblum; J C Marie
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

5.  Differentiation versus proliferation of transgenic mouse lens cells expressing polyoma large T antigen: evidence for regulation by an endogenous growth factor.

Authors:  A E Griep; H Westphal
Journal:  New Biol       Date:  1990-08

6.  Spontaneous electrical activity regulates vasoactive intestinal peptide expression in dissociated spinal cord cell cultures.

Authors:  D V Agoston; L E Eiden; D E Brenneman; I Gozes
Journal:  Brain Res Mol Brain Res       Date:  1991-06

7.  A fatty neuropeptide. Potential drug for noninvasive impotence treatment in a rat model.

Authors:  I Gozes; M Fridkin
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Penile erection: possible role for vasoactive intestinal polypeptide as a neurotransmitter.

Authors:  B Ottesen; G Wagner; R Virag; J Fahrenkrug
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-07

9.  Regulated expression of a diphtheria toxin A-chain gene transfected into human cells: possible strategy for inducing cancer cell suicide.

Authors:  I H Maxwell; F Maxwell; L M Glode
Journal:  Cancer Res       Date:  1986-09       Impact factor: 12.701

10.  Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglial mitogen.

Authors:  D E Brenneman; T Nicol; D Warren; L M Bowers
Journal:  J Neurosci Res       Date:  1990-03       Impact factor: 4.164

View more
  20 in total

1.  Lateralized hippocampal effects of vasoactive intestinal peptide on learning and memory in rats in a model of depression.

Authors:  Margarita Ivanova; Stiliana Belcheva; Iren Belcheva; Negrin Negrev; Roman Tashev
Journal:  Psychopharmacology (Berl)       Date:  2011-12-08       Impact factor: 4.530

2.  Spatiotemporal distribution of vasoactive intestinal polypeptide receptor 2 in mouse suprachiasmatic nucleus.

Authors:  Sungwon An; Connie Tsai; Julie Ronecker; Alison Bayly; Erik D Herzog
Journal:  J Comp Neurol       Date:  2012-08-15       Impact factor: 3.215

3.  VIP-PACAP 2010: my own perspective on modulation of cognitive and emotional behavior.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2010-11       Impact factor: 3.444

4.  VIP, from gene to behavior and back: summarizing my 25 years of research.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2008-07-08       Impact factor: 3.444

Review 5.  A VIP hybrid antagonist: from developmental neurobiology to clinical applications.

Authors:  I Gozes; M Fridkin; D E Brenneman
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

6.  Protection against developmental deficiencies by a lipophilic VIP analogue.

Authors:  I Gozes; M Bachar; A Bardea; A Davidson; S Rubinraut; M Fridkin
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

7.  Identification of VIP/PACAP receptors on rat astrocytes using antisense oligodeoxynucleotides.

Authors:  O Ashur-Fabian; E Giladi; D E Brenneman; I Gozes
Journal:  J Mol Neurosci       Date:  1997-12       Impact factor: 3.444

8.  A glia-derived signal regulating neuronal differentiation.

Authors:  O Blondel; C Collin; W J McCarran; S Zhu; R Zamostiano; I Gozes; D E Brenneman; R D McKay
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

9.  Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo.

Authors:  Eliezer Giladi; Joanna M Hill; Efrat Dresner; Conor M Stack; Illana Gozes
Journal:  J Mol Neurosci       Date:  2007-10-02       Impact factor: 3.444

Review 10.  Neuropeptides of the pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide/growth hormone-releasing hormone/secretin family in testis.

Authors:  Min Li; Akira Arimura
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.